Synthesis and binding monitoring of a new nanomolar PAMAM-based matrix metalloproteinases inhibitor (MMPIs)
作者:Linda Cerofolini、Veronica Baldoneschi、Elisa Dragoni、Andrea Storai、Marianna Mamusa、Debora Berti、Marco Fragai、Barbara Richichi、Cristina Nativi
DOI:10.1016/j.bmc.2016.11.028
日期:2017.1
enhancement of the residence time of drugs in the eyes. In this context, the synthesis of the PAMAM-based matrix metalloproteinases inhibitor 5, is reported. In particular, we demonstrated that 5 strongly binds (18.0 nM ± 2.5 nM) MMP-9, the most relevant MMP responsible of ocular surface damages in induced dry eyes syndrome (DES).
树状聚合物是有效的药物递送系统,在眼部疾病中特别有用。特别是,低代PAMAM树状聚合物是无毒且无免疫原性的,它们可延长药物在眼睛中的停留时间。在这种情况下,报道了基于PAMAM的基质金属蛋白酶抑制剂5的合成。特别是,我们证明了5个强结合(18.0 nM±2.5 nM)MMP-9,这是引起干眼症(DES)眼表损伤的最相关MMP。